glp-1 pregnancy category Navigating and Pregnancy: Insights, Safety, and Postpartum Considerations A new study found reassuring

Liraglutide (Saxenda, Novo Nordisk) was further developed with a higher dosage than Victoza for chronic weight management, and was approved by the FDA in 2014, proving its weight loss effects in numerous clinical studies performed worldwide [20,21]

Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial

in the second half of 2024

Its increasingly becoming the standard for good psychiatric practice, at least for those of us who specialize in complex cases where standard approaches havent worked

These agents include semaglutide (Ozempic for diabetes, Wegovy for obesity), liraglutide (Victoza for diabetes, Saxenda for obesity), dulaglutide (Trulicity, diabetes only), and tirzepatide (Mounjaro for diabetes, Zepbound for obesity)with tirzepatide being a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist